Search icon
Learn, Analyse & Invest
only with
Orca logoArrow icon
+91
Download Orca
orca play storeorca apple store
To access realtime data for Reliance Industries Ltd, and use advance features for tradingRegisterorLogin to Orca.

Achyut Healthcare Ltd.

Achyut Healthcare

0.00

0.00 (0.00)%

NSE

BSE

EX-DatePurpose
26 05 2022 Audited Results
03 09 2022 Inter alia, to consider and approve : 1. To call 27th Annual General Meeting of the Company and decide the time, date, day and venue of the meeting. 2. To consider and approve Notice of 27th Annual General Meeting, Director?s Report for the year ending 31st March, 2022. 3. To approve the appointment of M/s Doshi Doshi & Co. (Firm Reg. No. : 153683W) as Statutory Auditor of the Company. 4. To fix the date of Book Closure of the Company. 5. Any other item with the permission of the Chair and Majority of Directors.
12 11 2022 Half Yearly Results
21 11 2022 Preferential Issue of shares & Increase in Authorised Capital
05 01 2023 Preferential Issue of shares (Revised)
18 03 2023 Bonus issue & Inter alia, to transact the following business; 1. To consider and recommend bonus issue of equity shares. 2. To fix Record Date for the said bonus issue. 3. To appoint Scrutinizer to Scrutinize the Voting process in fair and transparent manner. 4. To consider and approve notice calling Extra Ordinary General Meeting. 5. Any other Business with the permission of Chair and majority of directors
27 05 2023 Audited Results
28 08 2023 A.G.M. & Inter alia, to transact following business:- 1. To call 28th Annual General Meeting of the Company and decide the time, date, day and venue of the meeting. 2. To consider and approve Notice of 28th Annual General Meeting & Director?s Report for the year ending 31st March, 2023. 3. To Appoint Mr. Kamlesh M Shah & Co., PCS as Scrutinizers for the e.voting process of the company?s ensuing AGM to be held as OAVM. 4. To fix the date of Book Closure of the Company. 5. Any other item with the permission of the Chair and Majority of Directors.
04 11 2023 Half Yearly Results
15 11 2023 Preferential Issue of shares & Increase in Authorised Capital
19 10 2024 Half Yearly Results & Stock Split & Bonus issue & Increase in Authorised Capital Inter alia, to transact following business :- 1. To consider and approve the unaudited financial result of the Company for the half year ended on 30th September, 2024. 2. To consider and approve Sub-Division of the face value of equity share subject to necessary approvals. 3. To consider and approve Increase in Authorized Capital of the Company subject to approval of the members; 4. To recommend and approve issue of Bonus shares post sub-division of shares to the equity shareholders of the Company. 5. To consider and approve the related party transaction disclosure under regulation 23 (9) of SEBI (Listing obligations and Disclosure Requirements), 2015 for the half year ended 30th September, 2024.
17 04 2025 Inter alia, to transact following business: 1. To consider and approve migration of listing/trading of equity shares of the Company from SME Platform of BSE to Main Board of BSE in terms of Chapter IX of SEBI (ICDR) Regulations, 2018 subject to necessary approvals. 2. Any other item with the permission of the Chair and Majority of Directors
29 05 2025 Audited Results
02 09 2025 A.G.M.
16 10 2025 Half Yearly Results
17 01 2026 Increase in Authorised Capital & Preferential Issue of shares & Quarterly Results
21 01 2026 Quarterly Results

News

No Data Available

No News data available

Enrich money logo